» Articles » PMID: 3040216

Primary Liver Cancer in Japan. Sixth Report. The Liver Cancer Study Group of Japan

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1987 Sep 15
PMID 3040216
Citations 41
Affiliations
Soon will be listed here.
Abstract

The Liver Cancer Study Group of Japan statistically analyzed 4658 cases of primary liver cancer diagnosed from January 1, 1980 to December 31, 1981 in over 400 hospitals throughout the country. The study group comprised 2038 cases of hepatocellular carcinoma, 146 of cholangiocarcinoma, 33 of mixed carcinoma, 30 of hepatoblastoma, six of sarcoma, and 33 others. In 2286 cases (49.1%) a histologic diagnosis was available. The survey, based mostly on the histologically proven cases, describes histologic features of the tumors, grade of anaplasia and growth patterns of the tumor cells, pathology in noncancerous portions of the liver, distant metastases, medical history, frequency of hepatitis in the history, frequency of positive HBsAg and anti-HBs, age distribution, subjective symptoms, radiographic features (angiogram, scintiscan, computed tomography), ultrasonography, surgical procedures, extent of hepatic resection, and survival.

Citing Articles

Hepatocellular Carcinoma in Non-Fibrotic Liver: A Narrative Review.

Naganuma H, Ishida H Diagnostics (Basel). 2023; 13(22).

PMID: 37998562 PMC: 10670297. DOI: 10.3390/diagnostics13223426.


Surveillance, Diagnosis, and Treatment Outcomes of Hepatocellular Carcinoma in Japan: 2021 Update.

Kudo M Liver Cancer. 2021; 10(3):167-180.

PMID: 34239807 PMC: 8237798. DOI: 10.1159/000516491.


Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan.

Kudo M, Izumi N, Kubo S, Kokudo N, Sakamoto M, Shiina S Hepatol Res. 2019; 50(1):15-46.

PMID: 31655492 PMC: 7003938. DOI: 10.1111/hepr.13438.


Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.

Santini D, Pantano F, Riccardi F, Di Costanzo G, Addeo R, Guida F PLoS One. 2014; 9(8):e105268.

PMID: 25170882 PMC: 4149423. DOI: 10.1371/journal.pone.0105268.


What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot Study.

Kawamura Y, Ikeda K, Fukushima T, Seko Y, Hara T, Sezaki H Gut Liver. 2013; 7(5):576-84.

PMID: 24073316 PMC: 3782673. DOI: 10.5009/gnl.2013.7.5.576.